Korean Drug Co., Ltd.

A014570

KR7014570006

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
6,230 ^KRW	0.00%		+1.14%	-13.23%

2023	Korean Drug Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2021	Tranche Update on Korean Drug Co., Ltd.'s Equity Buyback Plan announced on December 14, 2020.	CI

Korea Securities Finance Corporation acquired 3.64% stake in Korean Drug Co. Ltd..

January 08, 2015 at 11:00 pm EST

Korea Securities Finance Corporation acquired 3.64% stake in Korean Drug Co. Ltd. (KOSDAQ:A014570) on January 9, 2015. Korea Securities Finance Corporation acquired 0.4 million shares of Korean Drug Co. Ltd.

Korea Securities Finance Corporation completed the acquisition of 3.64% stake in Korean Drug Co. Ltd. (KOSDAQ:A014570) on January 9, 2015.

Latest news about Korean Drug Co., Ltd.

Korean Drug Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-14	CI
Tranche Update on Korean Drug Co., Ltd.'s Equity Buyback Plan announced on December 14, 2020.	21-03-01	CI
Tranche Update on Korean Drug Co., Ltd.'s Equity Buyback Plan announced on December 14, 2020.	21-03-01	CI
Korean Drug Co., Ltd.'s Equity Buyback announced on December 14, 2020, has closed with 14,000 shares, representing 0.13% for KRW 143.66 million.	21-02-25	CI
Korean Drug Co., Ltd. announces an Equity Buyback for 14,000 shares.	20-12-14	CI
Korean Drug Co., Ltd. authorizes a Buyback Plan.	20-12-13	CI
Tranche Update on Korean Drug Co., Ltd.'s Equity Buyback Plan announced on December 11, 2018.	19-03-11	CI
Tranche Update on Korean Drug Co., Ltd.'s Equity Buyback Plan announced on December 11, 2018.	19-03-11	CI
Korean Drug Co., Ltd.’s Equity Buyback announced on December 11, 2018 has closed with 20,000 shares, for KRW 152.32 million.	19-03-05	CI
Korean Drug Co., Ltd. announces an Equity Buyback for 20,000 shares.	18-12-10	CI
Korean Drug Co. Ltd. authorizes a Buyback Plan.	18-12-10	CI
Tranche Update on Korean Drug Co. Ltd.'s Equity Buyback Plan announced on March 8, 2016.	16-06-06	CI
Korean Drug Co. Ltd.'s Equity Buyback announced on March 8, 2016 has closed with 15,000 shares, representing 0.14% for KRW 104.64 million.	16-06-01	CI
Korean Drug Co. Ltd. announces an Equity Buyback for 15,000 shares.	16-03-07	CI
Korean Drug Co. Ltd. authorizes a Buyback Plan.	16-03-07	CI
Tranche Update on Korean Drug Co. Ltd.'s Equity Buyback Plan announced on November 10, 2014.	15-02-08	CI
Korean Drug Co. Ltd.'s Equity Buyback announced on November 10, 2014 has closed with 20,000 shares, representing 0.18% for KRW 82.6 million.	15-02-01	CI
Korea Securities Finance Corporation acquired 3.64% stake in Korean Drug Co. Ltd..	15-01-08	CI
Korean Drug Co. Ltd. announces an Equity Buyback for 20,000 shares.	14-11-09	CI
Korean Drug Co. Ltd. authorizes a Buyback Plan.	14-11-09	CI
Korea Securities Finance Corporation, Investment Arm acquired a 4.2% stake in Korean Drug Co. Ltd..	14-04-11	CI
Tranche Update on Korean Drug Co. Ltd.'s Equity Buyback Plan announced on September 3, 2013.	13-12-01	CI
Korean Drug Co. Ltd.’s Equity Buyback announced on September 3, 2013 has closed with 53,000 shares, representing 0.47% for KRW 170.43 million.	13-11-25	CI
Korean Drug Co. Ltd. authorizes a Buyback Plan.	13-09-02	CI
Korean Drug Co. Ltd. announces an Equity Buyback for 53,000 shares.	13-09-02	CI

Chart Korean Drug Co., Ltd.

Duration

Period

More charts

Company Profile

KOREAN DRUG CO.,LTD is a Korea-based company engaged in the manufacture and distribution of pharmaceuticals. The Companyâs products portfolio consists of over-the-counter (OTC) medicines, ethical (ETC) medicines and health food, including multi-symptom cold medicines, blood-forming nutrients, treatments for central nervous system, remedies for respiratory diseases, dermatological agents, vitamins, antifungal agents, antipyretics, analgesics, anti-inflammatory drugs, antibiotics, allergic treatments, calcium and vitamin D tablets and home pregnancy test kits, among others.

Sector

Pharmaceuticals

Calendar

2024-08-12 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
KOREAN DRUG CO., LTD.	-13.23%	50.24M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.63%	44.12B
OTSUKA HOLDINGS CO., LTD.	+22.99%	22.71B
SANDOZ GROUP AG	+18.22%	15.15B
CIPLA LIMITED	+12.66%	13.61B
ZYDUS LIFESCIENCES LIMITED	+60.18%	13.34B
ONO PHARMACEUTICAL CO., LTD.	-8.35%	6.84B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+12.92%	5.63B

Generic Pharmaceuticals

Korean Drug Co., Ltd.

Equities

A014570

KR7014570006

Pharmaceuticals

Korea Securities Finance Corporation acquired 3.64% stake in Korean Drug Co. Ltd..

Latest news about Korean Drug Co., Ltd.

Chart Korean Drug Co., Ltd.

Company Profile

Income Statement Evolution

Sector Generic Pharmaceuticals